NEW YORK, NY / ACCESSWIRE / March 15, 2017 / Cavitation Technologies, Inc. (OTCQB: CVAT; Berlin: WTC) is an innovative leader in processing liquids, fluidic mixtures, emulsions and suspended solids by manufacturing state-of-the-art patented hydrodynamic cavitation-based devices and systems. Cavitation Technologies, Inc. (CTi) announced today that it will be presenting at the Sidoti & Company Spring 2017 Convention on March 29th at 11:00 AM EDT. Chairman of the Business Committee and Board Member, Dr. Raymond G. Bailey, will be presenting, as well as meeting with investors.
Sidoti & Company is the preeminent, institutional-quality equity research provider on Wall Street covering small- and micro-cap equities. We are building interest and visibility into the most overlooked, undervalued segment of the equity market. Sidoti & Company aims to unite small- and micro-cap companies together with quality investors.
News Compliments of ACCESSWIRE.
About Cavitation Technologies, Inc.
Founded in 2007, the company designs and manufactures state-of-the-art, flow-through, devices and systems, as well as develops processing technologies for use in edible oil refining, renewable fuel production, expeditious petroleum upgrading, algae oil extraction, alcoholic beverage enhancement, water treatment, and cannabidiol processing. As an add-on to its existing neutralization systems, the company's patented Nano ReactorTM allows refiners to significantly reduce both processing costs and environmental impact, while also increasing yield.
Website: http://www.ctinanotech.com/
Investor Relations Website: www.CVAT.info
Follow us on Twitter: https://twitter.com/ctinanotech
Like us on Facebook: https://www.facebook.com/ctinanotech
About Sidoti & Company
Sidoti & Company, LLC is Wall Street's preeminent provider of equity research generally focused on companies with market capitalizations of under $3 billion. We cover over 250 companies across a range of industries. The companies covered by our traditional research typically have a history of profitability, maintain strong balance sheets, and tend to have limited, if any, coverage by other Wall Street firms.
Our approach affords institutional investor clients a combination of high-quality research, a small- and micro-cap company focused nationwide sales effort, broad access to corporate management teams, and extensive trading support. We serve nearly 500 institutional clients in the U.S., Canada and the U.K., including many leading managers of portfolios with $200 million to $2 billion of assets. We believe that these asset managers are generally underserved by other larger brokerage firms that typically target larger managers.